Cite
Stefanini GG, Briguori C, Cao D, et al. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. Eur Heart J. 2021;42(45):4683-4693doi: 10.1093/eurheartj/ehab533.
Stefanini, G. G., Briguori, C., Cao, D., Baber, U., Sartori, S., Zhang, Z., Dangas, G., Angiolillo, D. J., Mehta, S., Cohen, D. J., Collier, T., Dudek, D., Escaned, J., Gibson, C. M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Kunadian, V., Moliterno, D. J., Ohman, E. M., Oldroyd, K. G., Sardella, G., Sharma, S. K., Shlofmitz, R., Weisz, G., Witzenbichler, B., Pocock, S., & Mehran, R. (2021). Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. European heart journal, 42(45), 4683-4693. https://doi.org/10.1093/eurheartj/ehab533
Stefanini, Giulio G, et al. "Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD." European heart journal vol. 42,45 (2021): 4683-4693. doi: https://doi.org/10.1093/eurheartj/ehab533
Stefanini GG, Briguori C, Cao D, Baber U, Sartori S, Zhang Z, Dangas G, Angiolillo DJ, Mehta S, Cohen DJ, Collier T, Dudek D, Escaned J, Gibson CM, Gil R, Huber K, Kaul U, Kornowski R, Krucoff MW, Kunadian V, Moliterno DJ, Ohman EM, Oldroyd KG, Sardella G, Sharma SK, Shlofmitz R, Weisz G, Witzenbichler B, Pocock S, Mehran R. Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD. Eur Heart J. 2021 Dec 01;42(45):4683-4693. doi: 10.1093/eurheartj/ehab533. PMID: 34423374.
Copy
Download .nbib